An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

DUEXIS®

Drug Information Related Patent
Hold Company
HORIZON
Learn More
Dosage and Administration
TABLET;ORAL
Specification
26.6MG;800MG
Indication
DUEXIS® is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis and to reduce the risk of upper gastrointestinal ulcers.
Use
Instructions for Use
API
FAMOTIDINE
IBUPROFEN
API Structure
We Supply
FAMOTIDINE
Note:

CP/JP/Commercial
Facility GMP
DMF

IBUPROFEN
Note:

CP/BP/EP/USP/JP
Facility GMP
Product GMP
DMF/CEP/FDA/PMDA

null
Note:

null

Drug Patent
Patent NoExpiration Date
80674512026/7/18
83091272026/7/18
83182022026/7/18
84499102026/7/18
85012282026/7/18
80670332026/7/18
API Patent
Patent NoExpiration Date
80674512026/7/18
83091272026/7/18
83182022026/7/18
84499102026/7/18
85012282026/7/18
80670332026/7/18

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top